Bariatric surgery
Surgical procedures to manage obesity and related conditions.
Wikipedia / Wikimedia Commons
Bariatric surgery—also called metabolic or weight-loss surgery—encompasses several operations designed to treat obesity and its associated health problems. Lasting weight loss from these procedures can happen through changes in gut hormones, physically shrinking the stomach, limiting how many nutrients the body absorbs, or a mix of these methods. The most common operations are Roux-en-Y gastric bypass, sleeve gastrectomy, and biliopancreatic diversion with duodenal switch. In these procedures, weight loss largely comes from resetting the body’s hormonal signals for hunger and fullness, establishing a new weight set point.
For people with severe obesity, this surgery is the most effective way to lose weight and lower the risk of complications. A 2021 analysis of multiple studies found that bariatric surgery reduced the chance of death from any cause in obese adults, whether or not they had type 2 diabetes. That same analysis showed that obese adults with diabetes who had surgery lived, on average, 9.3 years longer than those who received standard, non-surgical care. For obese adults without diabetes, the gain was 5.1 years. The risk of dying shortly after the operation is less than 1 in 1,000. Beyond weight loss, the surgery can also improve cardiovascular risk factors, fatty liver disease, and diabetes control.
These stomach-reducing operations are often used when diet and exercise alone haven’t worked, or when obesity is already harming a person’s health and well-being. They work by limiting how much food a person can eat, and some also reduce the absorption of carbohydrates, fats, calories, and protein. The result is usually a significant drop in body mass index (BMI). How well a specific procedure works depends on its type, with the two main categories being sleeve gastrectomy and gastric bypass.
As of October 2022, the American Society of Metabolic and Bariatric Surgery and the International Federation for the Surgery of Obesity recommended considering surgery for adults with a BMI over 35, regardless of other health conditions, and for those with a BMI between 30 and 35 who also have metabolic syndrome. These BMI cutoffs don’t apply the same way to all groups. For Asian populations, surgery may be considered at a BMI above 27.5. Similarly, the American Academy of Pediatrics recommends surgery for adolescents aged 13 and older whose BMI is more than 1
- field
- Surgery
- known_for
- Effective treatment for obesity and related conditions
- procedures
- Roux en-Y bypass, sleeve gastrectomy, biliopancreatic diversion with duodenal switch
- mortality_risk
- Less than 1 in 1,000
- life_expectancy_gain_diabetes
- 9.3 years
- life_expectancy_gain_no_diabetes
- 5.1 years
Lore & Background
Bariatric surgery has proven to be the most effective obesity treatment option for enduring weight loss. Along with weight reduction, the procedure reduces risk of cardiovascular diseases, type 2 diabetes, fatty liver disease, and depression syndromes. Historically, eligibility was defined as a BMI greater than 40, or a BMI more than 35 with an obesity-associated comorbidity, based on the 1991 NIH Consensus Statement. In October 2022, the American Society of Metabolic and Bariatric Surgery and the International Federation for the Surgery of Obesity revised eligibility criteria to include all adult patients with a BMI greater than 35, and those with a BMI more than 30 with metabolic syndrome. For Asian populations, surgery may be considered at a BMI more than 27.5.
Reader's Guide
Bariatric surgery is significant as the most effective treatment for morbid obesity and reducing complications. A 2021 meta-analysis found it associated with reduction in all-cause mortality among obese adults with or without type 2 diabetes, with median life-expectancy gains of 9.3 years for those with diabetes and 5.1 years for those without. The risk of death in the period following surgery is less than 1 in 1,000. The procedure also lowers disease risk, including improvement in cardiovascular disease risk factors, fatty liver disease, and diabetes management. Studies report 85–90% resolution of type 2 diabetes after surgery, with remission rates up to 74% two years post-surgery. Relative risk reductions are 61%, 64%, and 77% for development of type 2 diabetes, hypertension, and dyslipidemia, respectively. Barriers to shared decision making include lack of insurance coverage, lack of knowledge about procedures, and conflicts with organizational priorities. The American Academy of Pediatrics recommends surgery for adolescents 13 and older with a BMI greater than 120% of the 95th percentile for age and sex.
Did You Know?
- Bariatric surgery is associated with a reduction in all-cause mortality among obese adults with or without type 2 diabetes.
- Median life-expectancy gain is 9.3 years for obese adults with diabetes who received bariatric surgery compared to routine care.
- The risk of death in the period following surgery is less than 1 in 1,000.
- Studies report 85–90% resolution of type 2 diabetes after bariatric surgery.
Frequently Asked Questions
Who is Bariatric surgery?
Bariatric surgery is a family of metabolic and weight-loss operations created to treat obesity and its associated health complications. It works by reshaping the digestive tract so the body processes food and hunger hormones differently.
What are Bariatric surgery's powers/role?
Its core ability is producing lasting weight loss through a mix of physically shrinking the stomach, limiting nutrient absorption, and resetting gut-hormone signals that govern hunger and fullness. It also serves as a direct treatment for obesity-related conditions such as type 2 diabetes.
How does Bariatric surgery's story end?
The long-term arc is strongly positive: patients without diabetes gain roughly 5.1 years of life expectancy, while those with diabetes see a 9.3-year gain. The procedure carries a mortality risk of fewer than 1 in 1,000 cases.
Why is Bariatric surgery important?
It stands as one of the most effective interventions for severe obesity and its metabolic complications, delivering results that medication and lifestyle changes alone frequently cannot match. It has fundamentally reshaped how the medical community approaches chronic weight-related disease.
What are Bariatric surgery's main allies?
Its most recognized procedures are the Roux-en-Y gastric bypass, the sleeve gastrectomy, and the biliopancreatic diversion with duodenal switch. Each combines restriction and, in some cases, malabsorption in a slightly different way to drive weight loss.
More in Surgery & Trauma 1-24
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record